Targeting IL-17A for Treatment-Resistant Depression

Clinical trial NCT04979910 · COMPLETED

Trial details

NCT number: NCT04979910
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2021-08-27
Primary completion: 2024-04-12
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.